Solid phase extraction method for the detection of nitrofurans in animal-derived foods (SilibaseTM C8/SAX)
First, the purpose of the experiment
In this experiment, solid phase extraction was used as a pretreatment method for samples, and LC-MS/MS method was used as a detection method. This method simplifies the pre-treatment of the sample and saves the amount of organic solvent.
Second, the experimental target
Furazolidone (CAS: 67-45-8), furantitone (CAS: 139-91-3), nitrofurazone (CAS: 59-87-0), nitrofurantoin (CAS: 67-20-9).
Third, the scope of application
The method is suitable for LC-MS/MS detection and confirmation of nitrofuran drugs in animal-derived foods.
Fourth, the reference standard
Recommended national standard "GB/T 21311-2007 Determination of nitrofuran metabolite residues in animal-derived foods by high performance liquid chromatography-tandem mass spectrometry".
V. Experimental materials
Biocomma® SilibaseTM C8/SAX Solid Phase Extraction Column 200mg/6mL.
Sixth, experimental methods
1, sample preparation
The sample tissue was ground and homogenized. Accurately weigh about 1g (accurate to 0.01g) sample in a 15mL screw tube with screw cap, add 1mL water and 8mL methanol, vortex and mix evenly, centrifuge at 2000r/min for 3min (<15 °C), discard the supernatant Add 8mL ethanol, vortex and mix evenly, centrifuge at 2000r/min for 3min (<15°C), discard the supernatant; add 8mL ethyl acetate, vortex and mix evenly, centrifuge at 2000r/min for 3min (<15°C), discard Go to the supernatant.
2. Hydrolysis and derivatization
To the quality control and the sample and the sample to be tested, 5 mL of a 0.2 mol/L aqueous hydrochloric acid solution, 100 μL of a derivatizing reagent, and 100 μL of an internal standard working solution (20 μg/L) and a mixed standard solution (10 μg/L) were added. The lid was capped, thoroughly shaken and mixed, then placed in an air bath shaker and derivatized at 37 ° C, 200 r / min for 16 h (overnight).
3, sample extraction
500 μL of a 0.3 M sodium phosphate aqueous solution was added. Add 10 mol/L sodium hydroxide solution to the test tube, vortex and mix well, adjust the pH value to 7.0-7.2 with precision pH test paper. Centrifuge for 10 min at 9500 r/min, and take the supernatant.
4, SPE column purification
(1) Activation: Pretreatment with 5 mL of methanol and 5 mL of pure water in this order.
(2) Elution: The supernatant was all passed through the column, and the flow rate was controlled at about 1 drop per second. The column was rinsed with 5 mL of water and 5 mL of 50% methanol/water solution in that order. After the eluent has completely passed through the cartridge, evacuate it for at least 5 min. Elution was carried out with 4 mL of 4% methanolic ammonia and the eluent was collected using a 15 mL test tube.
(3) Concentration and constant volume: nitrogen gas was dried at 40 °C. The residue was dissolved in a 0.05% formic acid/methanol solution (9:1, v/v). The solution was filtered through a 0.22 μm aqueous phase filter and the filtrate was used directly for LC-MS/MS analysis.
5. LC-MS/MS conditions
Liquid chromatography-mass spectrometry/mass spectrometer
Column: C18 column: 150mm × 2.1mm, 2.0μm, or equivalent
Mobile phase: methanol - 5 mM ammonium acetate
Seven, the experimental results
1. Add recycling results
 Different levels of tetracyclines were added to the samples, and the recovery results were as follows: (See Table 1)
Table 1 Results of tetracycline drug addition and recovery in animal tissues
sample name | Compound name | Add level (ng/mL) | Recovery rate(%) |
pork | Furazolidone | 50 | 80.75 |
100 | 82.58 | ||
Furanone | 50 | 89.74 | |
100 | 90.88 | ||
Furancillin | 50 | 92.74 | |
100 | 91.28 | ||
Nitrofurantoin | 50 | 95.63 | |
100 | 96.94 |
2, blank sample added pesticide residue chromatogram
Related Products
PolybaseTM MCX Solid Phase Extraction Column
Related applications
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shanghai Rocatti Biotechnology Co., Ltd. is a professional enterprise of rehabilitation and medical device products with sales and service as the main body. Since its establishment, the company has been committed to the development of medical devices. Its products involve the production of epidemic prevention materials such as gynecology (obstetrics), Urology, neurosurgery, kn95 medical protective masks, daily use flat masks, and the research and development of total nutrition slimming food. It can provide a complete range of first, second and third class medical device configuration schemes for general hospitals and specialized hospitals.
Nonwoven Face Mask,Non-Woven Facial Face Mask,Non-Woven Face Mask Ffp2,Non-Woven Surgical Face Mask
Shanghai Rocatti Biotechnology Co.,Ltd , https://www.ljdmedicals.com